Trial · NCT03595618
Adverse events364
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 364
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Arthralgia | Musculoskeletal and connective tissue disorders | GLPG1972 75 mg | 26 | 234 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | GLPG1972 150 mg | 34 | 231 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | GLPG1972 300 mg | 26 | 232 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Placebo | 19 | 234 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | GLPG1972 75 mg | 11 | 234 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | GLPG1972 150 mg | 10 | 231 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | GLPG1972 300 mg | 6 | 232 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Placebo | 19 | 234 | |
| other | Nasopharyngitis | Infections and infestations | GLPG1972 75 mg | 21 | 234 | |
| other | Nasopharyngitis | Infections and infestations | GLPG1972 150 mg | 16 | 231 | |
| other | Nasopharyngitis | Infections and infestations | GLPG1972 300 mg | 22 | 232 | |
| other | Nasopharyngitis | Infections and infestations | Placebo | 20 | 234 | |
| other | Upper respiratory tract infection | Infections and infestations | GLPG1972 75 mg | 7 | 234 | |
| other | Upper respiratory tract infection | Infections and infestations | GLPG1972 150 mg | 12 | 231 | |
| other | Upper respiratory tract infection | Infections and infestations | GLPG1972 300 mg | 6 | 232 | |
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 10 | 234 | |
| other | Gamma-glutamyltransferase increased | Investigations | GLPG1972 75 mg | 3 | 234 | |
| other | Gamma-glutamyltransferase increased | Investigations | GLPG1972 150 mg | 2 | 231 | |
| other | Gamma-glutamyltransferase increased | Investigations | GLPG1972 300 mg | 16 | 232 | |
| other | Gamma-glutamyltransferase increased | Investigations | Placebo | 4 | 234 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03595618/events